• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC Biozorb; MARKER, RADIOGRAPHIC, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC Biozorb; MARKER, RADIOGRAPHIC, IMPLANTABLE Back to Search Results
Model Number F0202
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Erythema (1840); Inflammation (1932); Necrosis (1971); Scar Tissue (2060); Seroma (2069); Breast Mass (2439); Breast Discomfort/Pain (4504)
Date of Event 06/05/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.This report is being submitted pursuant to 21 cfr part 803 based on information made available to hologic through litigation.Consistent with 21 cfr 803.16, the submission of this report is not intended, and shall not be construed, as an admission, acknowledgment, or confirmation by hologic that the device caused or contributed to the reportable event.
 
Event or Problem Description
Hologic has received correspondence arising from litigation.The litigation alleges that post right breast lumpectomy on (b)(6) 2019, a patient received a biozorb device implant.It is alleged that the patient has subsequently experienced persistent tenderness and discomfort at the lumpectomy site as well as seroma, scar tissue and palpable mass in the region of the biozorb.It is further alleged that the patient experienced worsening pain and erythema and was treated with antibiotics.It is alleged that on (b)(6) 2025, the patient underwent surgical excision of the mass, which included explantation of the biozorb and removal of surrounding necrotic tissue.This report is being submitted pursuant to 21 cfr part 803 based on information made available to hologic through litigation.Consistent with 21 cfr 803.16, the submission of this report is not intended, and shall not be construed, as an admission, acknowledgment, or confirmation by hologic that the device caused or contributed to the reportable ev.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Biozorb
Common Device Name
MARKER, RADIOGRAPHIC, IMPLANTABLE
Manufacturer (Section D)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer (Section G)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer Contact
dara smithers
600 technology drive
newark, DE 19702
MDR Report Key24604641
Report Number1222780-2026-00117
Device Sequence Number10343521
Product Code NEU
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K143484
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 09/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberF0202
Device Catalogue NumberF0202
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/16/2026
Supplement Date Received by Manufacturer09/24/2026
Initial Report FDA Received Date03/16/2026
Supplement Report FDA Received Date09/30/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-